Impact of tumor grade on prognosis in pancreatic cancer: Should we include grade in AJCC staging?

Annals of Surgical Oncology

Volumn 17, Issue 9, 2010, Pages 2312-2320

  Wasif, Nabil ^a   Ko, Clifford Y ^b,c   Farrell, James ^b   Wainberg, Zev ^b   Hines, Oscar J ^b   Reber, Howard ^b   Tomlinson, James S ^b,c  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; DATA BASE; FEMALE; GENDER; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PANCREAS CANCER; PREDICTOR VARIABLE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

ADENOCARCINOMA; AGED; COHORT STUDIES; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROGNOSIS; SEER PROGRAM; SURVIVAL RATE;

EID: 77956310443     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1071-7     Document Type: Article

References (28)

1. FL Greene LH Sobin 2008 The staging of cancer: a retrospective and prospective appraisal CA Cancer J Clin. 58 180 190 10.3322/CA.2008.0001 18460593
2. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, et al., editors. American joint committee on cancer: AJCC cancer staging manual. 6th ed. New York, NY: Springer; 2002.
3. KY Bilimoria DJ Bentrem CY Ko J Ritchey AK Stewart DP Winchester, et al. 2007 Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database Cancer. 110 738 744 10.1002/cncr.22852 17580363
4. MF Brennan MW Kattan D Klimstra K Conlon 2004 Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas Ann Surg. 240 293 298 10.1097/01.sla.0000133125.85489.07 15273554
5. CR Ferrone MW Kattan JS Tomlinson SP Thayer MF Brennan AL Warshaw 2005 Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival J Clin Oncol. 23 7529 7535 10.1200/JCO.2005.01.8101 16234519
6. RJ Geer MF Brennan 1993 Prognostic indicators for survival after resection of pancreatic adenocarcinoma Am J Surg. 165 68 72 10.1016/S0002- 9610(05)80406-4 1:STN:280:DyaK3s7hvVynsQ%3D%3D 8380315
7. JE Lim MW Chien CC Earle 2003 Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients Ann Surg. 237 74 85 10.1097/00000658-200301000-00011 12496533
8. Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J, et al. 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg. 2006;10:1199-210.
9. G Benassai M Mastrorilli G Quarto A Cappiello U Giani P Forestieri, et al. 2000 Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas J Surg Oncol. 73 212 218 10.1002/(SICI)1096- 9098(200004)73:4<212::AID-JSO5>3.0.CO;2-D 1:STN:280:DC%2BD3c3lvF2hsg%3D%3D 10797334
10. C Gebhardt W Meyer M Reichel PH Wünsch 2000 Prognostic factors in the operative treatment of ductal pancreatic carcinoma Langenbecks Arch Surg. 385 14 20 10.1007/s004230050004 1:STN:280:DC%2BD3c7jtFSksw%3D%3D 10664114
11. KF Kuhlmann SM de Castro JG Wesseling FJ ten Kate GJ Offerhaus OR Busch, et al. 2004 Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients Eur J Cancer. 40 549 558 10.1016/j.ejca.2003.10.026 1:STN:280:DC%2BD2c%2FntlKgsw%3D%3D 14962722
12. Kumar V, Fausto N, Abbas A. Robbins and Cotran pathologic basis of disease. 7th ed. Philadelphia: Saunders; 2004.
13. Havener L. Standards for cancer registries volume III: standards for completeness, quality, analysis, and management of data. Springfield, IL: North American Association of Central Cancer Registries; 2004.
14. Surveillance, Epidemiology, and End Results (SEER) Program. Public use data (1973-2005). National Cancer Institute. http://www.seer.cancer.gov. Accessed October 2008.
15. RE Schwarz DD Smith 2006 Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database Ann Surg Oncol. 13 1189 1200 10.1245/s10434-006-9016-x 16955385
16. JS Tomlinson S Jain DJ Bentrem EG Sekeris MA Maggard OJ Hines, et al. 2007 Accuracy of staging node-negative pancreas cancer: a potential quality measure Arch Surg. 142 767 773 10.1001/archsurg.142.8.767 17709731
17. S Takai S Satoi H Toyokawa H Yanagimoto N Sugimoto K Tsuji, et al. 2003 Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience Pancreas. 26 243 249 10.1097/00006676-200304000-00007 1:STN:280:DC%2BD3s7kt12hsQ%3D%3D 12657950
18. C Sperti C Pasquali A Piccoli S Pedrazzoli 1996 Survival after resection for ductal adenocarcinoma of the pancreas Br J Surg. 83 625 631 10.1002/bjs.1800830512 1:STN:280:DyaK283ps1agug%3D%3D 8689203
19. B Kedra T Popiela M Sierzega A Precht 2001 Prognostic factors of long-term survival after resective procedures for pancreatic cancer Hepatogastroenterology. 48 1762 1766 1:STN:280:DC%2BD38%2Fos1egtw%3D%3D 11813619
20. SS Nitecki MG Sarr TV Colby JA van Heerden 1995 Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 221 59 66 10.1097/00000658-199501000-00007 1:STN:280:DyaK2M7is1OhtQ%3D%3D 7826162
21. CP Raut JF Tseng CC Sun H Wang RA Wolff CH Crane, et al. 2007 Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma Ann Surg. 246 52 60 10.1097/01.sla.0000259391.84304.2b 17592291
22. AM Lightner RE Glasgow TH Jordan AD Krassner LW Way SJ Mulvihill, et al. 2004 Pancreatic resection in the elderly J Am Coll Surg. 198 697 706 10.1016/j.jamcollsurg.2003.12.023 15110802
23. E Finlayson Z Fan JD Birkmeyer 2007 Outcomes in octogenarians undergoing high-risk cancer operation: a national study J Am Coll Surg. 205 729 734 10.1016/j.jamcollsurg.2007.06.307 18035254
24. H Oettle S Post P Neuhaus K Gellert J Langrehr K Ridwelski, et al. 2007 Adjuvant chemotherapy with gemcitabine vs. observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial JAMA. 297 267 277 10.1001/jama.297.3.267 1:CAS:528:DC%2BD2sXotVCmug%3D%3D 17227978
25. JP Neoptolemos DD Stocken H Friess C Bassi JA Dunn H Hickey, et al. 2004 European Study Group for Pancreatic Cancer. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med. 350 1200 1210 10.1056/NEJMoa032295 1:CAS:528:DC%2BD2cXit12rtr8%3D 15028824
26. VJ Picozzi PW Pisters SM Vickers SM Strasberg 2008 Strength of the evidence: adjuvant therapy for resected pancreatic cancer J Gastrointest Surg. 12 657 661 10.1007/s11605-007-0446-y 18157582
27. NV Adsay O Basturk M Bonnett N Kilinc AA Andea J Feng, et al. 2005 A proposal for a new and more practical grading scheme for pancreatic ductal adenocarcinoma Am J Surg Pathol. 29 724 733 10.1097/01.pas.0000163360.40357.f1 15897739
28. IA Eltoum MA Eloubeidi DC Chhieng A Tamhane R Crowe D Jhala, et al. 2005 Cytologic grade independently predicts survival of patients with pancreatic adenocarcinoma Am J Clin Pathol. 124 697 707 10.1309/044P-L9GT-0C3D-B4N4 16203289